ACGN(Delisted)
AceragenยทNASDAQ
--
--(--)
ACGN Profile
Aceragen, Inc.
A company that develops therapeutic treatments for pulmonary and rheumatic diseases
505 Eagleview Blvd., Suite 212, 19341, Exton, Pennsylvania 19341
--
Aceragen, Inc., is incorporated in Delaware. Aceragen is a clinical-stage biopharmaceutical company dedicated to transforming the care of people with rare lung and rheumatic diseases. Their portfolio includes late-stage projects based on mature biological principles that they are developing as innovative therapies that address the unmet medical needs of individuals with rare diseases.
